Monlunabant in adults with obesity and metabolic syndrome: Open-label extension of a phase 2a trial. uri icon

Overview

publication date

  • March 24, 2026

Identity

Digital Object Identifier (DOI)

  • 10.1111/dom.70580

PubMed ID

  • 41877358